223
Participants
Start Date
June 14, 2019
Primary Completion Date
December 28, 2022
Study Completion Date
January 27, 2023
Lungpacer Diaphragm Pacing Therapy
Transvenous phrenic nerve stimulation to induce diaphragm contraction.
Berlin Charite Mitte, Berlin
Universitätsmedizin Greifswald, Greifswald
Temple University Hospital, Philadelphia
Prisma Health Baptist Hospital, Columbia
University of Florida, Shands, Gainesville
CHU Montpellier, Montpellier
University of Louisville, Louisville
Solingen Krankenhaus Bethanien, Solingen
Ohio State University, Columbus
Cleveland Clinic Foundation, Cleveland
University of Cincinnati, Cincinnati
KEM Essen, Essen
Indiana University Health Methodist Hospital, Indianapolis
CHU Angers, Angers
Minneapolis Heart Institute Foundation, Minneapolis
FKKG Schmallenberg, Schmallenberg
Edward Hines VA Hospital, Hines
Loyola University Medical Center, Maywood
Northwestern University Feinberg School of Medicine, Chicago
Rush University Medical Center, Chicago
U of Illinois at Chicago, Chicago
CHU Strasbourg, Strasbourg
CHI Health Creighton University Medical Center - Bergan Mercy, Omaha
SLK Löwenstein, Löwenstein
University of Texas Southwestern, Zale Lipshy Hospital, Dallas
Hôpital La Pitié-Salpêtrière, Paris
University of Colorado Anschutz Medical Campus, Aurora
University of Utah, Salt Lake City
Nürnberg Klinikum Nord, Nuremberg
Stanford University Medical Center, Stanford
Lahey Hospital and Medical Center, Burlington
Englewood Hospital Medical Center, Englewood
Kent County Memorial Hospital, Warwick
Lead Sponsor
Lungpacer Medical Inc.
INDUSTRY